licensing agreement

Centhaquine is a resuscitative agent to treat hypovolemic shock by increasing stroke volume and cardiac output due to an increase…

Leuprolide acetate for depot suspension is a GnRH agonist used for the treatment of advanced prostatic cancer, endometriosis, and…

Nidlegy, currently in Phase III clinical trials, is a new anti-cancer biopharmaceutical which is being developed by Philogen for…

The partnership aims to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify in the US

mTOR inhibitors prevent age-related physiologic decline and lengthen healthspan 

Collaboration focuses on up to three types of lung and gastrointestinal (GI) cancers

'Covi-G' has been commercialised in 20+ countries, with sensitivity and specificity exceeding 92 per cent, informs company

It is currently being evaluated in a multi-site Phase 1/2 clinical trial in children and young adults with relapsed or refractory…

Dr Reddy’s would have exclusive rights for development, selling and distribution of Avigan in India.

Dr Reddy’s will receive technology transfer from Gilead for manufacturing of this drug and needs to do the manufacturing scale-up…